Icon

TEMODAR (nda021029)- (5MG,20MG,100MG,140MG,180MG,250MG)

TEMOZOLOMIDE MERCK SHARP DOHME
5MG,20MG,100MG,140MG,180MG,250MG
Yes No
2014-Feb-11 Expired
2012-Mar-15 None
None No
TEMODAR is an alkylating drug indicated for the treatment of adult patients with: • Newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment. • Refractory anaplastic astrocytoma who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.
11 0 9
Total Other Developers None
Drugs with Suitability No
5MG ** ** - - -
20MG ** ** - - 6
100MG ** ** - - 5
140MG ** ** - - 6
180MG ** ** - - -
250MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******** ******* *********** *********** *** ****** *** ******, ********, ******** *** ***, ****** (***) ***
****** ******** ********** *********** *** *** *********** ***-********** ****, ****-*****, ******** ******** ******* **, **** *****, *******, ****** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. * ** **, *******, **** ******* ******, *******-***** *******, **. *-*, ****** ******, *********, ******* ******, ***** (***) ***
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ****** ****** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ***** *** ********* *.*.* *********** *** ***** ******* **, ********, ****** *****, ***** (***) ***
****** ****** ***** ****** ************ ******* *********** ****-*, **. **. ***, *** & ***, ******* *******, ********* ******, *******-**********, ********* ******, ***** (***) ***
****** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ****, *****, ***, ************, ********** ******, **********, ********* ******, ***** (***) ***
****** ****** ***** ************** **., ***. ****** ***** *********** **. ** ********* *** **., ******* *******, ****** ****,****** ******, - *****, ****** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** **** ******* ** **** ******* ****** ******* - ********* * ****** ****** ****** *********** ********* ******** ****** ***, **:** ******** ********* ***** *******, *******, ********, *****, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.